Evidence map›Paper›PMID 40419468›Full record

ArticleNature communications2025

Duplication of the autism-related gene Chd8 leads to behavioral hyperactivity and neurodevelopmental defects in mice.

Atsuki Kawamura, Kazuki Fujii, Kota Tamada, Yoshifumi Abe, Kenta Nitahara, Tomoya Iwasaki, Sho Yagishita, Kenji F Tanaka, Toru Takumi, Keizo Takao and 1 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Male-Biased Social Deficits in Chd8Neuroscience bulletin · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Atsuki KawamuraDepartment of Histology and Cell Biology, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Ishikawa, Japan.
Kazuki FujiiDepartment of Behavioral Physiology, Faculty of Medicine, University of Toyama, Toyama, Japan.
Kota TamadaDepartment of Physiology and Cell Biology, Kobe University School of Medicine, Chuo, Kobe, Japan.ORCID http://orcid.org/0000-0002-6575-6189
Yoshifumi AbeDivision of Brain Sciences, Institute for Advanced Medical Research, Keio University School of Medicine, Tokyo, Japan.
Kenta NitaharaDepartment of Histology and Cell Biology, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Ishikawa, Japan.
Tomoya IwasakiDepartment of Histology and Cell Biology, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Ishikawa, Japan.
Sho YagishitaLaboratory of Structural Physiology, Center for Disease Biology and Integrative Medicine, Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
Kenji F TanakaDivision of Brain Sciences, Institute for Advanced Medical Research, Keio University School of Medicine, Tokyo, Japan.ORCID http://orcid.org/0000-0003-2511-0057
Toru TakumiDepartment of Physiology and Cell Biology, Kobe University School of Medicine, Chuo, Kobe, Japan.ORCID http://orcid.org/0000-0001-7153-266X
Keizo TakaoDepartment of Behavioral Physiology, Faculty of Medicine, University of Toyama, Toyama, Japan.ORCID http://orcid.org/0000-0002-4734-3583
Masaaki NishiyamaDepartment of Histology and Cell Biology, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Ishikawa, Japan. nishiyam@staff.kanazawa-u.ac.jp.ORCID http://orcid.org/0009-0002-6868-1749

Funding

Japan Agency for Medical Research and Development (AMED) JP22gm6310008Japan Agency for Medical Research and Development (AMED) JP24wm0625001Japan Agency for Medical Research and Development (AMED) JP24wm0625308Japan Agency for Medical Research and Development (AMED) JP24wm0625316MEXT | Japan Society for the Promotion of Science (JSPS) JP21H02847MEXT | Japan Society for the Promotion of Science (JSPS) JP21H05619MEXT | Japan Society for the Promotion of Science (JSPS) JP21J00911MEXT | Japan Society for the Promotion of Science (JSPS) JP21K15726MEXT | Japan Society for the Promotion of Science (JSPS) JP22H05493MEXT | Japan Society for the Promotion of Science (JSPS) JP23K14795MEXT | Japan Society for the Promotion of Science (JSPS) JP24H00627
6 · The paper itself

Abstract

Mutations in the gene encoding chromodomain helicase DNA-binding protein 8 (CHD8) are strongly associated with autism spectrum disorder (ASD). Although duplications of the chromosomal locus including CHD8 have also been detected in individuals with neurodevelopmental disorders, the contribution of CHD8 duplication to clinical phenotypes and the underlying mechanisms have remained unknown. Here we show that Chd8 knock-in (KI) mice that overexpress CHD8 as a model of human CHD8 duplication manifest growth retardation, microcephaly, impaired neuronal differentiation, and behavioral abnormalities including hyperactivity and reduced anxiety-like behavior. Chd8 overexpression affects the transcription and chromatin accessibility of genes related to neurogenesis, with these changes being associated with aberrant binding of CHD8 to enhancer regions. Furthermore, pharmacological intervention partially ameliorates the hyperactivity of Chd8 KI mice. Our results thus indicate that Chd8 KI mice recapitulate key features of CHD8 duplication syndrome in humans, providing insight into pathogenic mechanisms underlying neurodevelopmental disorders.

Indexed as

Autism Spectrum DisorderDNA-Binding ProteinsGene DuplicationHyperkinesisNeurodevelopmental DisordersTranscription FactorsAnimalsAnxietyAutistic DisorderBehavior, AnimalDisease Models, AnimalFemaleGene Knock-In TechniquesHumansMaleMiceCHD8 protein, humanDNA-Binding Proteinsduplin protein, mouseTranscription Factors

Identifiers

PMID40419468
PMCPMC12106843

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.